NDC Compounded Drug 72627-4001-2 Ketamine Hydrochloride
Injection Intramuscular; Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Ketamine Hydrochloride
NDC crossover of Ketamine with NDC 72627-4001 a human compounded drug with other similar products matching the same substance name (Ketamine Hydrochloride) and the same administration route (intramuscular; intravenous) or dosage form (injection).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
63037-136-25 | Ketamine Hcl | Ketamine Hcl | 5 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
63037-136-25 | Ketamine Hcl | Ketamine Hcl | 5 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
63037-136-25 | Ketamine Hcl | Ketamine Hcl | 5 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
63037-136-25 | Ketamine Hcl | Ketamine Hcl | 5 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
63037-137-25 | Ketamine Hcl | Ketamine Hcl | 1 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
63037-137-25 | Ketamine Hcl | Ketamine Hcl | 1 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
63037-137-25 | Ketamine Hcl | Ketamine Hcl | 1 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
63037-137-25 | Ketamine Hcl | Ketamine Hcl | 1 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
65302-529-05 | Ketamine Hydrochloride | Ketamine Hydrochloride | 5 mL in 1 SYRINGE | Injection | Intramuscular; Intravenous | The Ritedose Corporation |
70092-119-44 | Ketamine 10 Mg/ml In 5ml Ns Syr | Ketamine 10 Mg/ml In 5ml Ns Syr | 5 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-119-44 | Ketamine 10 Mg/ml In 5ml Ns Syr | Ketamine 10 Mg/ml In 5ml Ns Syr | 5 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-119-44 | Ketamine 10 Mg/ml In 5ml Ns Syr | Ketamine 10 Mg/ml In 5ml Ns Syr | 5 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-119-44 | Ketamine 10 Mg/ml In 5ml Ns Syr | Ketamine 10 Mg/ml In 5ml Ns Syr | 5 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-120-43 | Ketamine 50 Mg/ml 1 Ml- 3 Ml Syr | Ketamine 50 Mg/ml 1 Ml- 3 Ml Syr | 1 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-120-43 | Ketamine 50 Mg/ml 1 Ml- 3 Ml Syr | Ketamine 50 Mg/ml 1 Ml- 3 Ml Syr | 1 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-120-43 | Ketamine 50 Mg/ml 1 Ml- 3 Ml Syr | Ketamine 50 Mg/ml 1 Ml- 3 Ml Syr | 1 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-120-43 | Ketamine 50 Mg/ml 1 Ml- 3 Ml Syr | Ketamine 50 Mg/ml 1 Ml- 3 Ml Syr | 1 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-563-43 | Ketamine 10 Mg/ml In 2 Ml Ns- 3 Ml Syr | Ketamine 10 Mg/ml In 2 Ml Ns- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-563-43 | Ketamine 10 Mg/ml In 2 Ml Ns- 3 Ml Syr | Ketamine 10 Mg/ml In 2 Ml Ns- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-563-43 | Ketamine 10 Mg/ml In 2 Ml Ns- 3 Ml Syr | Ketamine 10 Mg/ml In 2 Ml Ns- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-563-43 | Ketamine 10 Mg/ml In 2 Ml Ns- 3 Ml Syr | Ketamine 10 Mg/ml In 2 Ml Ns- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
71506-050-56 | Ketamine Hydrochloride | Ketamine Hydrochloride | 100 mL in 1 BAG | Injection | Intravenous | Fresenius Kabi Compounding Llc Dba Fagron Sterile Services |
71506-050-56 | Ketamine Hydrochloride | Ketamine Hydrochloride | 100 mL in 1 BAG | Injection | Intravenous | Fresenius Kabi Compounding Llc Dba Fagron Sterile Services |
71506-050-56 | Ketamine Hydrochloride | Ketamine Hydrochloride | 100 mL in 1 BAG | Injection | Intravenous | Fresenius Kabi Compounding Llc Dba Fagron Sterile Services |
71506-050-56 | Ketamine Hydrochloride | Ketamine Hydrochloride | 100 mL in 1 BAG | Injection | Intravenous | Fresenius Kabi Compounding Llc Dba Fagron Sterile Services |
71506-074-05 | Ketamine Hydrochloride | Ketamine Hydrochloride | 5 mL in 1 SYRINGE | Injection | Intravenous | Fresenius Kabi Compounding Llc Dba Fagron Sterile Services |
71506-074-05 | Ketamine Hydrochloride | Ketamine Hydrochloride | 5 mL in 1 SYRINGE | Injection | Intravenous | Fresenius Kabi Compounding Llc Dba Fagron Sterile Services |
71506-074-05 | Ketamine Hydrochloride | Ketamine Hydrochloride | 5 mL in 1 SYRINGE | Injection | Intravenous | Fresenius Kabi Compounding Llc Dba Fagron Sterile Services |
71506-074-05 | Ketamine Hydrochloride | Ketamine Hydrochloride | 5 mL in 1 SYRINGE | Injection | Intravenous | Fresenius Kabi Compounding Llc Dba Fagron Sterile Services |
72627-4000-2 | Ketamine | Ketamine | 10 mL in 1 VIAL, SINGLE-DOSE | Injection | Intramuscular; Intravenous | Empower Pharmacy |
Frequently Asked Questions
What is the NDC number assigned to Ketamine?
Ketamine was assigned by its manufacturer with NDC product code 72627-4001. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Ketamine?
The NDC package code 72627-4001-2 was assigned to a 10 mL in 1 VIAL, MULTI-DOSE of ketamine hydrochloride administered intramuscular; intravenous via injection.
Who manufactures this product?
Ketamine is manufactured by an outsourced facility and labeled by Empower Pharmacy. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 30 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Hikma Injectables USA Inc., The Ritedose Corporation, QuVa Pharma, Inc., Fresenius Kabi Compounding LLC DBA Fagron Sterile Services and Empower Pharmacy with NDC product codes 63037-136-25, 63037-136-25, 63037-136-25, 63037-136-25, 63037-137-25, 63037-137-25, 63037-137-25, 63037-137-25, 65302-529-05, 70092-119-44, 70092-119-44, 70092-119-44, 70092-119-44, 70092-120-43, 70092-120-43, 70092-120-43, 70092-120-43, 70092-563-43, 70092-563-43, 70092-563-43, 70092-563-43, 71506-050-56, 71506-050-56, 71506-050-56, 71506-050-56, 71506-074-05, 71506-074-05, 71506-074-05, 71506-074-05 and 72627-4000-2.